Skip to main content

Aptevo Therapeutics Inc 8-K, filed Oct 23, 2026

Aptevo Therapeutics Inc. (APVO)

8-K 2026-10-23 For: 2026-10-23
View Original
Added on October 26, 2026

About this 8-K

Aptevo Therapeutics Inc filed this 8-K on October 23, 2026.

Aptevo Therapeutics amended its Rights Agreement with Broadridge Corporate Issuer Solutions via Amendment No. 6, extending the Final Expiration Date to October 23, 2027. It changes the Purchase Price from $70 to $14.56 per one one-thousandth of a Preferred Share. AI summary

Items reported

  • Item 1.01: Entered into a material agreement
  • Item 3.03: Change to shareholders' rights
  • Item 9.01: Financial statements and exhibits